2026 NPPES data Optometrist NPI 1043764780 O.D.
Verify on CMS →

JOSEPH BUENTELLO, O.D.

Optometrist in EDINBURG, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 663 beneficiaries · Optometrist avg: 257
Generic prescribing
34%
generic claims · 66% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
98.6639/100
▲ 16 pts above national avg 83.1 · [object Object]
Industry payments
$944.72
37 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

JOSEPH BUENTELLO, O.D. reported a CMS MIPS final score of 98.6639/100 — above the 83.1 national average — and filed 1,929 Medicare Part D claims in 2023.

98.6639/100
MIPS score · +16 vs avg
2K
Part D claims, 2023
34%
generic prescribing
$944.72
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

JOSEPH BUENTELLO, O.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

99 Top 11% higher than 89% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

What does the federal data show about JOSEPH BUENTELLO, O.D.?

High performer (top quartile)

NPI registry status

Active

Issued 08/11/2016

NPI 1043764780

Primary specialty

Optometrist

High-volume

60,463 US NPIs in this specialty

Medicare Part D claims

1,929 651% vs specialty avg

2023 prescription claims

Specialty avg: 257

MIPS final score

98.6639/100 15.563900000000004% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Texas

How Optometrist compares to other specialties among Texas providers

Texas providers

Optometrist share within Texas

1. Optometrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Optometrist share within Texas

Medicare quality performance — MIPS

JOSEPH BUENTELLO, O.D.'s 2023 MIPS final score plotted against the Optometrist national average

High performer (top quartile)
MIPS Final Score
98.6639/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Optometrist) — 98.6639/100 vs national avg 83.1

0%100%National avg83%98.7%
MIPS final score (Optometrist) — 98.6639/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JOSEPH BUENTELLO, O.D. appears in the CMS NPPES registry as a Optometrist provider holding O.D. credentials at 2301 S US HIGHWAY 281, EDINBURG, TX, 78539, with a listed phone of (956) 383-5581. NPI 1043764780 was issued on 08/11/2016. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BUENTELLO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,929 prescription claims written by this provider, covering 663 Medicare beneficiaries and totaling roughly $677K in drug spend, split 66% brand-name and 34% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 98.6639/100 for the 2023 performance year (Quality 100, Cost 83.889), compared with the national average of 83.1.

Optometrist is a high-volume specialty nationwide, with 60,463 enrolled providers across 56 states and an average of 257 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2301 S US HIGHWAY 281
EDINBURG, TX 78539

Provider Details

NPI 1043764780
Specialty Optometrist
Credentials O.D.
Gender Male
NPI Issued 08/11/2016

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

98.6639
Final Score
Avg: 83.1
100
Quality
83.889
Cost

Reporting: Group practice

Hospital and facility affiliations

Facilities where JOSEPH BUENTELLO, O.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

EYE AND OCULAR SURFACE CENTER OF TEXAS LLC
EL PASO, TX

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for JOSEPH BUENTELLO, O.D.. Source: openpaymentsdata.cms.gov.

Total received

$945

Largest payer

Bausch & Lomb Americas Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to JOSEPH BUENTELLO, O.D.. To verify JOSEPH BUENTELLO, O.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

JOSEPH BUENTELLO, O.D. — brand share 66.0%
Specialty average (est.)

66% brand-name claims vs 34% generic, on 1,929 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,929
Total Claims
$677K
Total Drug Cost
663
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,416
Total Day Supply
63,014
Brand vs Generic
66% brand / 34% generic
Brand Drug Cost
$653K
Generic Drug Cost
$24K
Antibiotic Claims
114

Patient Demographics

Average Patient Age
71.1 years
Avg HCC Risk Score
1.81
Gender Split
65% female / 35% male
Age Distribution
<65: 83, 65-74: 391, 75-84: 151, 85+: 38

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What JOSEPH BUENTELLO, O.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Restasis
Cyclosporine
355
Latanoprost
260
Xiidra
Lifitegrast
181
Prednisolone Acetate
165
Tobramycin-Dexamethasone
Tobramycin/Dexamethasone
149
Neomycin-Polymyxin-Dexameth
Neomycin/Polymyxin B/Dexametha
136
Doxycycline Monohydrate
113
Loteprednol Etabonate
92
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
59
Lotemax Sm
Loteprednol Etabonate
55

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Optometrist Overview

How JOSEPH BUENTELLO, O.D. fits within the Optometrist landscape nationally.

60,463
Optometrist Providers in US
56
States with Optometrist
257
Avg Claims per Provider

JOSEPH BUENTELLO, O.D.'s 1,929 claims are above the specialty average of 257.

Nearby Optometrist Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as BUENTELLO.

Compare Optometrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is JOSEPH BUENTELLO, O.D.'s specialty?
JOSEPH BUENTELLO, O.D. specializes in Optometrist and practices in EDINBURG, Texas. Credentials: O.D..
How much does JOSEPH BUENTELLO, O.D. prescribe under Medicare Part D?
In 2023, JOSEPH BUENTELLO, O.D. wrote 1,929 Medicare Part D claims totaling $677K in drug costs for 663 beneficiaries.
What is JOSEPH BUENTELLO, O.D.'s Medicare quality score?
JOSEPH BUENTELLO, O.D. has a CMS MIPS Final Score of 98.6639/100 (Quality: 100, Cost: 83.889). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is JOSEPH BUENTELLO, O.D. located?
JOSEPH BUENTELLO, O.D. is located at 2301 S US HIGHWAY 281, EDINBURG, TX, 78539. Phone: (956) 383-5581.
What is JOSEPH BUENTELLO, O.D.'s NPI number?
JOSEPH BUENTELLO, O.D.'s National Provider Identifier (NPI) is 1043764780, issued on 08/11/2016.
Does JOSEPH BUENTELLO, O.D. prescribe more brand-name or generic drugs?
JOSEPH BUENTELLO, O.D.'s prescribing is 66% brand-name and 34% generic drugs by claim count, with $653K in brand drug costs.
How many Optometrist providers are there in the US?
There are 60,463 Optometrist providers across 56 states in the US. The average Optometrist provider writes 257 Medicare Part D claims per year.
What drugs does JOSEPH BUENTELLO, O.D. prescribe most often?
Based on 2023 Medicare Part D data, JOSEPH BUENTELLO, O.D.'s most frequently prescribed drugs include Restasis, Latanoprost, Xiidra. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does JOSEPH BUENTELLO, O.D. accept Medicare?
JOSEPH BUENTELLO, O.D. appears in CMS Medicare data with 1,929 Part D claims and 663 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JOSEPH BUENTELLO, O.D.'s credentials?
JOSEPH BUENTELLO, O.D.'s NPI is 1043764780 with credentials O.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology